5 day volume Average = 298,700
20 day volume Average = 627,810
90 day volume Average = 939,481
Add to wishlistAdded to wishlistRemoved from wishlist 0
Add to compare
3.8/10 (Expert Score)
Product is rated as #14 in category BM Health Care
Prospective Profit
4.941
Assets
1.596
Dividend/ Cash
1.305
Liquidity
7.206
PROS:
  • Profitable business
  • Small Dividend Payout
  • Very High Trading Value
CONS:
  • Very Low Price-to-Tangible
  • Company in Debt
  • Very High Gearing

klse: Pharmaniaga Bhd


Corporate Information

Board   : Main

Shariah : Shariah Compliant

Sector   : Ringgit Consumer Healthcare

Address: No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja Selatan, Seksyen 7, Shah Alam, 40000, Selangor

Contact: +603-33429999

Website: https://www.pharmaniaga.com/
 

Corporate Background

Pharmaniaga Berhad is an investment holding company. The Company, through its subsidiaries, manufactures, markets, and distributes pharmaceutical and medical products to government hospitals and private institutions. Pharmaniaga also provides web portal services for online trading of health care products.

Genaral Info: PHARMA 7081

Market Capital (RM) 887, 182, 431
Forecasted Profit or Loss (RM) 59, 727, 804
Estimated Future EPS (sen) 22.823
Perspective P/E ratio 14.854
Estimated Dividend Yield (%) 2.706
Adjusted NTA (RM) 0.772

Result

Quarter Report History

Date Revenue,k PBT,k Net Profit,k
17/03/21 634,583 -13,506 -6,331
19/11/20 624,804 4,093 1,442
19/08/20 645,763 14,326 9,979
19/05/20 819,921 30,880 22,399
20/02/20 715,683 -238,474 -178,598
20/11/19 716,849 3,885 481
23/08/19 601,890 12,481 9,281
16/05/19 786,108 30,243 19,617
21/02/19 596,644 11,940 4,437
19/11/18 587,660 17,603 15,051
17/08/18 582,729 11,970 5,394
16/05/18 617,923 28,707 17,586

Fundamental

Fundamental Analysis

Last 4 Quarter Revenue (RM’000) 2,725,071
Last 4 Quarter Net Profit (RM’000) 26,269
Last 4 Quarter EPS (sen) 10.51
Last 4 Quarter PER 33.77
Last 4 Quarter Dividend (sen) 11.00
Last 4 Quarter Dividend Yield (%) 3.24
Net Tangible Assets (RM) 1.29
Goodwill (RM) 193,810
Cash (RM’000) 36,540
Debt (RM’000) 733,290
Total Debt (RM’000) 1,400,000
Net Assets (RM’000) 345,560
Current Ratio 0.79
Quick Ratio 0.27
Cash Ratio 0.02

Technical

Technical Analysis

MACD (26 vs 12) -0.216
Exponential Moving Average 5 3.249
Exponential Moving Average 20 3.422
Exponential Moving Average 90 4.205
Relative Strength Index 14 0.30
Stochastic %D 3 0.24
Stochastic %K 14 0.23

10 reviews for PHARMA 7081

3.4 out of 5
3
1
2
3
0
Write a review
Show all Most Helpful Highest Rating Lowest Rating
  1. Avatar

    The Star

    Shares of Pharmaniga Bhd and Duopharma Biotech Bhd climbed in active trade on Wednesday as the companies sign agreement with the Government to supply Covid-19 vaccine. Pharmaniaga, one of the top gainers on Bursa Malaysia this morning, rose 3.01%, or 15 sen to RM5.13. Pharmaniaga said it would be supplying 12 million doses of Covid-19 vaccines developed by China’s Sinovac Life Sciences Co Ltd

    Helpful(0) Unhelpful(0)You have already voted this
  2. Avatar

    The Star

    Shares in Pharmaniaga Bhd rose over 5% in early trade Thursday following its partnership with China’s Sinovac Life Sciences Co Ltd. The pharmaceutical company added 5.62%, or 29 sen to RM5.45. In the past one year, the counter has risen some 156%. Pharmaniaga has signed an agreement with China’s Sinovac to purchase 14 million doses of ready-to-fill COVID-19 vaccines and later to manufacture the vaccine domestically. The group expects the vaccine to be distributed to the public by the end of March this year. This will cover 22% of the country’s total population.

    Helpful(0) Unhelpful(0)You have already voted this
  3. Avatar

    The Edge

    AmInvestment Bank Bhd (AmInvest) believes that Pharmaniaga Bhd would be the main distributor of the Covid-19 vaccine to local hospitals, and may appoint other companies to help distribute the vaccine nationwide. In terms of fill-finish companies, AmInvest said while a deal concerning Covid-19 vaccine’s fill-finish process has yet to materialise, the government seems to favour Duopharma Biotech Bhd and Pharmaniaga to undertake these processes.

    Helpful(0) Unhelpful(0)You have already voted this
  4. Avatar

    BURSA MALAYSIA

    In comparison with the immediate preceding quarter, the Group recorded a lower revenue of RM625 million for the current quarter. This was mainly due to reduced demand from both the concession business and the Indonesia business as a result of the Covid-19 pandemic, which saw limited access to doctors, clinics, pharmacies and hospitals. The Group recorded a PBT of RM4 million, compared with RM14 million in the immediate preceding quarter

    Helpful(0) Unhelpful(0)You have already voted this
  5. Avatar

    The Edge

    Shares in Pharmaniaga Bhd rose as much as 4.06% this morning after the pharmaceutical company marked its first task in the fill-and-finish vaccine process when it signed an agreement with Serum Institute of India Pvt Ltd, the world’s largest vaccine manufacturer by the number of doses produced. The two companies signed a memorandum of agreement, which will enable Pharmaniaga to purchase pneumococcal vaccines from Serum and subsequently use the technology and know-how licensed by them for the filling and finishing process. The fill-and-finish product will be marketed, distributed and sold exclusively in Malaysia by Pharmaniaga.

    Helpful(0) Unhelpful(0)You have already voted this
  6. Avatar

    BURSA MALAYSIA

    In comparison with the immediate preceding quarter, the Group recorded a lower revenue of RM646 million for the current quarter. This was mainly due to reduced demand from both the concession business and the Indonesia business as a result of the Covid-19 pandemic, which saw limited access to doctors, clinics, pharmacies and hospitals. The Group recorded a PBT of RM14 million, compared with RM31 million in the immediate preceding quarter.

    Helpful(0) Unhelpful(0)You have already voted this
  7. Avatar

    REMUNERATION STUDY

    In Financial Year End 2019, the directors’ remuneration was 1.93 million. It was low compared to average in listed companies, considering the employees’ remuneration of 195.9 million and auditor’s remuneration of 570 thousands

    Helpful(0) Unhelpful(0)You have already voted this
  8. Avatar

    BURSA MALAYSIA

    In comparison with preceding quarter, the Group’s revenue increased to RM820 million for the 1Q2020. This was primarily due to stronger demand from Government and private hospitals in Malaysia and Indonesia. The Group post a PBT of RM31 million compared with a deficit of RM238 million in preceding quarter. The loss was due to the revision in useful life of the rights to supply and provision of stock write-off as a result of the voluntary Ranitidine product recall.

    Helpful(0) Unhelpful(0)You have already voted this
  9. Avatar

    BURSA MALAYSIA

    The Group recorded a revenue of RM716 million for the current quarter as compared to RM717 million in preceding quarter. However, the Group recorded a LBT of RM238 million for the current quarter as compared to PBT of RM15 million in preceding quarter due to the revision in useful life of the rights to supply and provision of stock write off as a result of the voluntary Ranitidine product recall.

    Helpful(0) Unhelpful(0)You have already voted this
  10. Avatar

    INVESTING MALAYSIA

    PHARMA 21 JAN 20 – Pharmaniaga Bhd says its managing director (MD) Datuk Farshila Emran will leave the company when her contract expires at the end of March this year, confirming a report by theedgemarkets.com earlier today.

    Helpful(0) Unhelpful(0)You have already voted this
  11. Avatar

    Investing Malaysia

    Average investing volume for Pharmaniaga Bhd in the past three months in stock market was 296.7k lots

    Helpful(0) Unhelpful(0)You have already voted this
  12. Avatar

    Investing Malaysia

    PHARMA gets a score of 10.92 in our equity and assets quality test based on current share price of RM1.9

    Helpful(0) Unhelpful(0)You have already voted this
  13. Avatar

    Investing Malaysia

    Pharmaniaga Bhd gets a score of 10.15 in our stability test after the balance sheet, money statement study

    Helpful(0) Unhelpful(0)You have already voted this
  14. Avatar

    Investing Malaysia

    Stock code of 7081 in Bursa Malaysia declared adjusted 6.42% dividend yield in past few years

    Helpful(0) Unhelpful(0)You have already voted this
  15. Avatar

    Investing Malaysia

    PHARMA is estimated to have a profit consensus of 44.98 millions, with an adjusted market capitalization of 478.05 millions

    Helpful(0) Unhelpful(0)You have already voted this
  16. Avatar

    REMUNERATION STUDY

    In Financial Year End 2018, the directors’ remuneration was 2.32 million. It was low compared to average in listed companies, considering the employees’ remuneration of 164.6 million and auditor’s remuneration of 620 thousands

    Helpful(0) Unhelpful(0)You have already voted this

    Add a review

    Your email address will not be published.

    klse share price, target price, profit PER estimation
    Register New Account
    Name (required)
    Reset Password
    Compare items
    • Total (0)
    Compare